Sarah E. Bota

The Risk of Major Hemorrhage with CKD

Amber O. Molnar, Sarah E. Bota, Amit X. Garg et al. · Journal of the American Society of Nephrology · 2016 · 181 citations · Full text

Medicine, Nephrology, Clinical Epidemiology +15

Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age

J. Ariana Noel, Sarah E. Bota, William Petrcich et al. · JAMA Internal Medicine · 2019 · 150 citations · Full text

Medicine, Geriatric Medicine, Pharmacology +14

Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study

Silvia J. Leon, Reid Whitlock, Claudio Rigatto et al. · American Journal of Kidney Diseases · 2022 · 131 citations

Medicine, Nephrology, Pharmacology +17

Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population‐based cohort study

Seyed M. Hosseini‐Moghaddam, Alexandra M. Ouédraogo, Kyla L. Naylor et al. · Transplant Infectious Disease · 2020 · 83 citations

Medicine, Infectious Diseases, Surgery +16

Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence

Gregory L. Hundemer, Robert Talarico, Navdeep Tangri et al. · Clinical Journal of the American Society of Nephrology · 2021 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13